We are live on ! Find out more
Exane Derivatives

Exane Derivatives Portfolio holdings

AUM $174M Turnover 34.02%
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$571M
AUM Growth
+$64.7M
Cap. Flow
+$78M
Cap. Flow %
13.67%
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89
Avg Time Held Equity + Options
1.7 years
Top 10 Avg Time Held Equity + Options
0.7 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
1.7 years
Top 10 Avg Time Held Equity only
0.8 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$35.4M
2
STLA icon
Stellantis
STLA
+$22.2M
3
PEP icon
PepsiCo
PEP
+$18M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$6.64M
5
KSS icon
Kohl's
KSS
+$5.18M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$21.5M
2
EIDO icon
iShares MSCI Indonesia ETF
EIDO
+$11.1M
3
ETN icon
Eaton
ETN
+$4.76M
4
DAL icon
Delta Air Lines
DAL
+$4.4M
5
WU icon
Western Union
WU
+$4.14M

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.24%
2 Financials 13.76%
3 Consumer Discretionary 12.98%
4 Consumer Staples 8.41%
5 Energy 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UBS icon
1
UBS Group
UBS
$133B
$45.2M 7.93%
3,805,878
+2,886,544
+314% +$35.4M
2019 Q1
1 quarter
PEP icon
2
PepsiCo
PEP
$193B
$26.2M 4.6%
199,123
+140,351
+239% +$18M
2017 Q3
7 quarters
STLA icon
3
Stellantis
STLA
$9.8B
$21.6M 3.78%
+1,528,258
New +$22.2M
2019 Q2
0 quarters
DB icon
4
PUT
Deutsche Bank
DB
$59B
$18.6M 3.26%
25,657
-12,900
-33% -$99.5K
2016 Q3
11 quarters
RSX
5
DELISTED
VanEck Russia ETF
RSX
$14.9M 2.61%
629,731
-44,673
-7% -$978K
2014 Q4
18 quarters
EEM icon
6
iShares MSCI Emerging Markets ETF
EEM
$25.3B
$14.9M 2.61%
346,647
+2,148
+0.6% +$91.2K
2015 Q1
17 quarters
DB icon
7
Deutsche Bank
DB
$59B
$12.2M 2.15%
1,588,820
+671,935
+73% +$5.18M
2014 Q4
18 quarters
UBS icon
8
PUT
UBS Group
UBS
$133B
$12M 2.1%
71,923
-11,216
-13% -$137K
2016 Q3
11 quarters
EWW icon
9
iShares MSCI Mexico ETF
EWW
$1.58B
$11.9M 2.09%
275,128
+86,290
+46% +$3.87M
2018 Q4
2 quarters
EPHE icon
10
iShares MSCI Philippines ETF
EPHE
$133M
$10.3M 1.8%
288,512
+5,243
+2% +$181K
2016 Q4
10 quarters
MCHI icon
11
iShares MSCI China ETF
MCHI
$5.22B
$8.76M 1.54%
147,454
+41,542
+39% +$2.5M
2019 Q1
1 quarter
PEP icon
12
CALL
PepsiCo
PEP
$193B
$7.74M 1.36%
3,150
-2,374
-43% -$304K
2017 Q3
7 quarters
STLA icon
13
PUT
Stellantis
STLA
$9.8B
$7.34M 1.29%
11,830
+540
+5% +$7.84K
2016 Q3
11 quarters
GLD icon
14
SPDR Gold Trust
GLD
$118B
$7.21M 1.26%
54,133
+16,326
+43% +$2.02M
2017 Q2
8 quarters
FTI icon
15
TechnipFMC
FTI
$23.3B
$6.85M 1.2%
358,024
-131,871
-27% -$2.31M
2017 Q1
9 quarters
KSA icon
16
iShares MSCI Saudi Arabia ETF
KSA
$552M
$6.51M 1.14%
+197,335
New +$6.64M
2019 Q2
0 quarters
KSS icon
17
Kohl's
KSS
$2.55B
$6.23M 1.09%
131,146
+85,922
+190% +$5.18M
2017 Q1
9 quarters
BCE icon
18
BCE
BCE
$20.5B
$6.05M 1.06%
132,960
-36,800
-22% -$1.66M
2018 Q1
5 quarters
BUD icon
19
AB InBev
BUD
$158B
$5.73M 1.01%
64,815
+50,125
+341% +$4.3M
2019 Q1
1 quarter
STX icon
20
Seagate
STX
$106B
$4.6M 0.81%
97,754
+96,590
+8,298% +$4.49M
2017 Q4
6 quarters
GAP icon
21
The Gap Inc
GAP
$7.42B
$4.57M 0.8%
254,582
+145,775
+134% +$3.27M
2014 Q4
18 quarters
SPY icon
22
State Street SPDR S&P 500 ETF Trust
SPY
$744B
$4.54M 0.8%
15,500
+3,416
+28% +$984K
2017 Q2
8 quarters
AGN
23
DELISTED
Allergan plc
AGN
$4.43M 0.78%
26,440
+25,679
+3,374% +$3.56M
2018 Q2
4 quarters
CMI icon
24
Cummins
CMI
$55.6B
$4.39M 0.77%
25,651
-5,345
-17% -$875K
2017 Q1
9 quarters
MRK icon
25
Merck
MRK
$332B
$4.35M 0.76%
54,391
-3,496
-6% -$268K
2018 Q2
4 quarters

Similar funds

Exane Derivatives's Q2 2019 Portfolio in Review

As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Exane Derivatives deployed $78M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.

  • Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
  • Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
  • Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
  • Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
  • Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
  • Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
  • Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.